1 min read
Add as a preferred source on GoogleAttovia Therapeutics Posts Third-Quarter GAAP Loss of $0.76 Per Share
The figure covered the three months ended Sept. 30, 2026, on both basic and diluted bases.
Attovia Therapeutics, Inc. recorded a GAAP net loss of $0.76 per share for the third quarter of 2026, reporting its per-share result for the period ended Sept. 30.
The figure was the net loss per share attributable to common stockholders on both a basic and diluted basis. The financial statements were prepared under U.S. generally accepted accounting principles.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.